# Single Ascending Dose Safety Study of Oxfendazole

> **NCT01584362** · PHASE1 · WITHDRAWN · sponsor: **Johns Hopkins Bloomberg School of Public Health**

## Conditions studied

- Tenia Solium Infection

## Interventions

- **DRUG:** oxfendazole
- **DRUG:** placebo
- **DRUG:** oxfendazole
- **DRUG:** oxfendazole
- **DRUG:** oxfendazole
- **DRUG:** oxfendazole
- **DRUG:** oxfendazole

## Key facts

- **NCT ID:** NCT01584362
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-08
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** study conducted under Clinical Trials Agreement as NIAID registration NCT02234570
- **Last updated:** 2016-08-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01584362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01584362, "Single Ascending Dose Safety Study of Oxfendazole". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01584362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*